annb0t
Top 20
Cardinal Health, Inc. CAH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.93, which beat the Zacks Consensus Estimate of $1.75 by 10.3%. The bottom line also improved 2.1% year over year.
GAAP EPS in the quarter was $1.65 compared with $1.50 in the year-ago period.
Revenue Details
Sales declined 3.8% on a year-over-year basis to $55.26 billion. However, the top line beat the Zacks Consensus Estimate by 0.7%.
Segmental Analysis
Pharmaceutical and Specialty Solutio...
>>> Read more: CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
GAAP EPS in the quarter was $1.65 compared with $1.50 in the year-ago period.
Revenue Details
Sales declined 3.8% on a year-over-year basis to $55.26 billion. However, the top line beat the Zacks Consensus Estimate by 0.7%.
Segmental Analysis
Pharmaceutical and Specialty Solutio...
>>> Read more: CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
